Tandem Health raises $50M Series A to scale its AI scribe across the NHS

Stockholm healthtech Tandem Health has raised $50 million Series A funding and has pledged that a “significant proportion” of the funds will be used to drive AI innovation within the NHS. The raise brings the company’s funding to over $109 million.

Tandem provides a clinician copilot that enables clinicians to focus on providing care, instead of on administrative tasks. Its ambient scribe listens during the patient consultation, transcribes it, and automatically generates a draft medical note that can seamlessly be transferred to your medical record system. 

Tandem's copilot fully follows GDPR and local patient data laws.

The company’s recent partnership with Accurx in the UK is bringing AI-assisted clinical documentation to 98 per cent of GPs in the UK, making it one of the largest AI scribe deployments in healthcare worldwide.

Tandem Health estimates that this funding will allow it to roll out to an additional 230,000 NHS staff who use Accurx in secondary care settings, like acute hospitals and community and mental health trusts, including 125,000 who use Accurx Mobile.

The news comes as the Government announced its intention to scale the use of technology like AI scribes across the NHS, as part of the NHS 10-Year Plan.

The healthtech business also plans to expand its UK-based clinical team, which supports NHS deployments and enhances interoperability with key medical data systems – including EMIS, SystmOne, Cerner, RiO and Epic – all of which are used within the NHS.

Kinnevik led the funding, with participation from Northzone, Amino Collective and will further accelerate Tandem’s development beyond an administrative AI medical assistant, towards an AI native operating system that supports every step of the clinical workflow.

In the UK, the investment will support the faster development of clinical templates and improvements to clinical coding systems, alongside deeper integration with electronic patient records (EPRs). 

Tandem also plans to develop new Class II medical device-certified modules and enhance the overall user experience of its AI assistant, with usability and patient safety as core priorities.

Ian Robertson, from Tandem Health UK, said: 

“We’re growing our UK-based clinical team to work hand-in-hand with frontline staff, and accelerating development of the product features that matter most: advanced template support, seamless EPR integration, and medical device-certified modules. 

The goal is clear: to build the most trusted clinical documentation assistant in the NHS.”

“We are just getting started with reimagining how healthcare will be delivered and how workflows are designed in the LLM era,” shares Lukas Saari, CEO and Co-founder of Tandem Health. 

“We seek to be the trusted long-term AI partner of healthcare providers, to support them in this transformational journey. In this, we are embracing the complexity that is European healthcare – already having established local operations in five markets – to provide the best tools that our clinicians deserve.”